Description: Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Home Page: www.sironabiochem.com
595 Burrard Street
Vancouver,
BC
V7X 1L4
Canada
Phone:
604 641 4466
Officers
| Name | Title |
|---|---|
| Dr. Howard J. Verrico M.D., Ph.D. | Founder, Chairman of the Board, CEO & Secretary |
| Mr. Christopher D. Hopton C.G.A., CPA | CFO & Director |
| Dr. Géraldine Deliencourt-Godefroy Ph.D. | Chief Scientific Officer & Director |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 33.8998 |
| Price-to-Sales TTM: | 322.8605 |
| IPO Date: | |
| Fiscal Year End: | October |
| Full Time Employees: | 0 |